USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $-0.17 | $-0.30 | $-0.63 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $2.63M | $385.00K | $2.77M |
Jaguar Health's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.10 | $-0.15 | $-0.05 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $-0.75 | $-0.75 | $-0.75 |
| Dec 2022 | 2 | $-0.60 | $-0.72 | $-0.48 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 1 / 0 | $-0.03 | $-0.02 | $0.00 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 1 / 0 | $-0.26 | $-0.21 | $-0.18 |
| Dec 2022 | 1 / 0 | $-0.21 | $-0.18 | $-0.20 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $8.74M | $4.80M | $12.68M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $14.08M | $11.70M | $16.47M |
| Dec 2022 | 2 | $25.05M | $19.21M | $30.90M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $-0.17 | - | - |
| Aug 13, 2021 | Jun 2021 | $-0.12 | $-0.30 | -150.00% |
| May 17, 2021 | Mar 2021 | $-0.06 | $-0.30 | -400.00% |
| Mar 31, 2021 | Dec 2020 | $-0.30 | $0.09 | 130.00% |
| Nov 16, 2020 | Sep 2020 | $-0.33 | $-0.63 | -90.91% |
| Aug 13, 2020 | Jun 2020 | $-0.45 | $-1.32 | -193.33% |
| Apr 3, 2020 | Mar 2020 | $-2.01 | $-2.04 | -1.49% |
| Nov 14, 2019 | Sep 2019 | $-2.31 | $-6.00 | -159.74% |
| Aug 14, 2019 | Jun 2019 | $-15.87 | $-45.33 | -185.63% |
| May 21, 2019 | Mar 2019 | $-39.90 | $-50.40 | -26.32% |
| Mar 13, 2019 | Dec 2018 | - | $-40.94 | - |
| Nov 19, 2018 | Sep 2018 | $-136.50 | $-35.62 | 73.90% |
| Aug 13, 2018 | Jun 2018 | - | $-53.24 | - |
| Apr 9, 2018 | Mar 2018 | $-136.50 | $-54.27 | 60.24% |
| Mar 14, 2018 | Dec 2017 | - | $-604.35 | - |
| Nov 20, 2017 | Sep 2017 | $-136.50 | $220.50 | 261.54% |
| Aug 9, 2017 | Jun 2017 | $-231.00 | $-126.00 | 45.45% |
| May 15, 2017 | Mar 2017 | - | $-349.72 | - |
| Feb 15, 2017 | Dec 2016 | $-0.24 | $-4.20 | -1650.00% |
| Nov 14, 2016 | Sep 2016 | $-0.40 | $-4.50 | -1025.00% |
| Aug 15, 2016 | Jun 2016 | $-0.38 | $-0.35 | 7.89% |
| May 10, 2016 | Mar 2016 | $-0.49 | $-0.43 | 12.24% |
| Mar 29, 2016 | Dec 2015 | $-0.64 | $-0.42 | 34.38% |
| Nov 13, 2015 | Sep 2015 | $-0.49 | $-0.36 | 26.53% |
| Aug 13, 2015 | Jun 2015 | - | $-1052.19 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 31, 2021 | Dec 2020 | $-0.85 | $-105.63 | - |
| Mar 13, 2019 | Dec 2018 | $0.00 | $-184.08 | - |
| Mar 14, 2018 | Dec 2017 | $0.00 | $-859.57 | - |
| Feb 15, 2017 | Dec 2016 | - | $-9.48 | - |
| Mar 29, 2016 | Dec 2015 | - | $-1052.97 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $2.63M | - | - |
| Aug 13, 2021 | Jun 2021 | $385.00K | $385.00K | 1.00% |
| May 17, 2021 | Mar 2021 | $7.40M | $1.24M | 0.17% |
| Mar 31, 2021 | Dec 2020 | $2.58M | $2.58M | 1.00% |
| Nov 16, 2020 | Sep 2020 | $7.80M | $2.77M | 0.36% |
| Aug 13, 2020 | Jun 2020 | $4.78M | $3.17M | 0.66% |
| Apr 3, 2020 | Mar 2020 | $2.49M | $1.51M | 0.61% |
| Nov 14, 2019 | Sep 2019 | $2.86M | $972.78K | 0.34% |
| Aug 14, 2019 | Jun 2019 | $3.00M | $1.71M | 0.57% |
| May 21, 2019 | Mar 2019 | - | $1.60M | - |
| Mar 13, 2019 | Dec 2018 | - | $1.60M | - |
| Nov 19, 2018 | Sep 2018 | - | $1.13M | - |
| Aug 13, 2018 | Jun 2018 | - | $883.85K | - |
| Apr 9, 2018 | Mar 2018 | $2.10M | $1.54M | 0.73% |
| Mar 14, 2018 | Dec 2017 | $1.54M | $1.54M | 1.00% |
| Nov 20, 2017 | Sep 2017 | - | $1.10M | - |
| Aug 9, 2017 | Jun 2017 | - | $896.52K | - |
| May 15, 2017 | Mar 2017 | - | $822.41K | - |
| Feb 15, 2017 | Dec 2016 | - | $28.88K | - |
| Nov 14, 2016 | Sep 2016 | - | $50.36K | - |
| Aug 15, 2016 | Jun 2016 | - | $24.14K | - |
| May 10, 2016 | Mar 2016 | - | $38.15K | - |
| Mar 29, 2016 | Dec 2015 | - | $55.19K | - |
| Nov 13, 2015 | Sep 2015 | - | $77.67K | - |
| Aug 13, 2015 | Jun 2015 | - | $63.14K | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 31, 2021 | Dec 2020 | $9.38M | $9.38M | 0.00% |
| Mar 13, 2019 | Dec 2018 | $15.85M | $4.42M | - |
| Mar 14, 2018 | Dec 2017 | $4.36M | $4.36M | 0.00% |
| Feb 15, 2017 | Dec 2016 | - | $141.52K | - |
| Mar 29, 2016 | Dec 2015 | - | $258.38K | - |
JAGX's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 2 analysts, the average EPS estimation for Jaguar Health's next quarterly earnings is $-0.17, with a low EPS estimation of $-0.20, and a high estimation of $-0.15.
Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.06, the last 2 month trend is $-0.05, and the 3 month trend is $-0.05.
Based on 2 analysts, the average revenue estimation is $2.63M, with a low revenue estimation of $2.16M, and a high estimation of $3.10M.
Jaguar Health's previous earnings date was Aug 13, 2021 for its fiscal quarter ended Jun 30, 2021.
JAGX's earnings per share (EPS) was $-0.30, missing the consensus analysts forecast of $-0.12 by -150.00%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by 0.00%, and higher than the same period a year before (Jun 2020) by -77.27%.
Revenues were $385.00K, better than the forecast of $385.00K by 0.00%, down by -68.98% from the previous quarter , and down by -87.84% from the same period last year.
The company reported a net income of $-14.08M.Free cash flow for the quarter was $-9.91M , compared to $-6.71M last quarter and $-4.00M a year before.
JAGX ended the quarter with $26.45M in total debt, an increase of 3.06% compared to the previous quarter, and an increase of 182.54% compared to the same quarter a year before.
Jaguar Health's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.
JAGX's earnings per share (EPS) was $-105.63.
Revenues were $9.38M, better than the forecast of $9.38M by 0.00%, and up by 62.50% from previous year's revenue.
The company reported a net income of $-33.81M.
Jaguar Health reported a free cash flow of $-15.29M for its fiscal year, compared to $-20.46M a year ago.
The company ended the fiscal year with $3.79M in total debt, a decrease of -49.91% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.